During the past decade, Pennsylvania Retina Specialists, P.C. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pennsylvania Retina Specialists, P.C." #1 sponsor was "Allergan" with 2 trials, followed by "ThromboGenics" with 2 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored, "National Eye Institute (NEI)" with 1 trials sponsored and "Notal Vision Ltd." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pennsylvania Retina Specialists, P.C." #1 collaborator was "MEDARVA Foundation" with 1 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Office of Dietary Supplements (ODS)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Pennsylvania Retina Specialists, P.C." are "Macular Degeneration" (2 trials), "Age Related Macular Degeneration" (1 trials), "Age-related Macular Degeneration" (1 trials), "Cataract" (1 trials) and "Geographic Atrophy" (1 trials). Many other conditions were trialed in "Pennsylvania Retina Specialists, P.C." in a lesser frequency.

Most popular intervention types in "Pennsylvania Retina Specialists, P.C." are "Drug" (6 trials), "Diagnostic Test" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "125 µg Ocriplasmin" (1 trials), "Abicipar Pegol" (1 trials), "Abicipar pegol" (1 trials) and "DHA/EPA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pennsylvania Retina Specialists, P.C." are 8 trials for "All" genders.

Currently, there are NaN active trials in "Pennsylvania Retina Specialists, P.C.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Pennsylvania Retina Specialists, P.C., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pennsylvania Retina Specialists, P.C., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".